AstraZeneca PLC (LSE:AZN) faced a blow on Friday after Deutsche Bank analysts downgraded the pharmaceuticals giant on what they labelled a “thoroughly disappointing” end to 2023.
Analysts wrote in a note that they saw shares in AstraZeneca falling over 300p on Thursday’s closing price to 9,500p, compared to previous guidance of a rise to 11,000p.
Unilever PLC (LSE:ULVR)’s trading update contained several pleasant surprises, according to Deutsche Bank, which has tweaked its numbers and stuck with a ‘buy’ recommendation.
“Gross margin surprised to the upside as did volume growth and this before the new management have fully mobilised their action plan,“ said the bank.
British Land’s capital markets event this week focused on redeveloping existing assets into lab space for the high-growth science & technology (sci-tech) sector.
More than just traditional life sciences, the sector also encompasses green & physical sciences, data, artificial technology (AI) and technology and already accounts for around 15% of the UK economy.
Arm Holdings PLC (NASDAQ:ARM)’s record quarterly revenues of $824 million (£652 million) caught the attention of Citi Bank analysts today, who said there were multiple drivers for the result, but “AI acceleration stands out”.
In a research note with a heavily shoehorned-in pun titled ‘rAIse your Arm agAIn’, Citi analysts wrote: “Arm delivered a very impressive beat and raise, even by already high semiconductor industry standards.